Safety and efficacy of esreboxetine in patients with fibromyalgia: A 14-week, randomized, double-blind, placebo-controlled, multicenter clinical trial
Arthritis & Rheumatism,  Clinical Article

Arnold LM et al. – Esreboxetine was generally well tolerated and associated with significant improvements in pain, Fibromyalgia Impact Questionnaire (FIQ), Patient Global Impression of Change (PGIC), and fatigue scores compared with placebo. The lack of a dose–response relationship in both the efficacy and safety analyses suggests that 4–mg/d esreboxetine would offer clinical benefit with the least risk of drug exposure.

Methods
  • Patients meeting American College of Rheumatology criteria for fibromyalgia were randomized to receive 4– (n = 277), 8– (n = 284), or 10–mg/d (n = 283) esreboxetine, or matching placebo (n = 278), for 14 weeks.
  • Primary efficacy outcomes were weekly mean pain score and Fibromyalgia Impact Questionnaire (FIQ) total score at week 14.
  • Secondary efficacy measures included Patient Global Impression of Change (PGIC), Global Fatigue Index (GFI), and 36–item Short–Form Health Survey (SF–36; Physical Functioning scale only) scores at week 14.
  • Esreboxetine's safety profile was evaluated based on adverse events and other safety measures.

Results
  • All doses of esreboxetine demonstrated statistically significant improvements over placebo on pain (P ≤ 0.025), FIQ (P ≤ 0.023), and PGIC (P ≤ 0.007).
  • Additionally, the 4– and 8–mg/d esreboxetine demonstrated statistically significant improvements over placebo on the GFI (P = 0.001).
  • No significant improvements over placebo were evident for any dose of esreboxetine on the SF–36 Physical Functioning scale.
  • Adverse events were mostly mild to moderate in severity; insomnia, constipation, dry mouth, nausea, dizziness, hot flush, headache, hyperhidrosis, and palpitations were reported most frequently.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Rheumatology Articles

1 Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: A nationwide cohort study Annals of Rheumatic Diseases, July 14, 2014    Clinical Article

2 Is minor salivary gland biopsy more than a diagnostic tool in primary Sjogren's syndrome? Association between clinical, histopathological, and molecular features: A retrospective study Seminars in Arthritis and Rheumatism, July 1, 2014    Clinical Article

3 Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis Joint, Bone, Spine, July 3, 2014    Clinical Article

4 Methotrexate and lung disease in rheumatoid arthritis – A meta-analysis of randomized controlled trials Arthritis & Rheumatism, December 27, 2013    Evidence Based Medicine    Review Article    Clinical Article

5 Anti-TNF-{alpha} therapy in patients with refractory uveitis due to Behcet's disease: A 1-year follow-up study of 124 patients Rheumatology, July 8, 2014    Clinical Article

6 Anti-cyclic citrullinated peptide antibody as a marker of erosive arthritis in patients with systemic lupus erythematosus: A systematic review and meta-analysis Lupus, July 11, 2014    Clinical Article

7 Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women American Journal of Clinical Nutrition, July 18, 2014    Review Article

8 Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: Drug-exposure limitations of oral methotrexate at doses >=15 mg may be overcome with subcutaneous administration Annals of Rheumatic Diseases, July 10, 2014    Clinical Article

9 An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegeners) Annals of Rheumatic Diseases, July 2, 2014

10 Therapeutic benefit of balneotherapy and hydrotherapy in the management of fibromyalgia syndrome: A qualitative systematic review and meta-analysis of randomized controlled trials Arthritis Research & Therapy, July 9, 2014    Evidence Based Medicine    Review Article

11 Ultrasound-detected musculoskeletal urate crystal deposition: Which joints and what findings should be assessed for diagnosing gout? Annals of Rheumatic Diseases, July 14, 2014    Clinical Article

12 Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis Seminars in Arthritis and Rheumatism, July 8, 2014    Clinical Article

13 Diagnostic accuracies of sialography and salivary ultrasonography in Sjögren`s syndrome patients: A meta-analysis Clinical and Experimental Rheumatology Online, July 16, 2014    Clinical Article

14 Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate Clinical and Experimental Rheumatology Online, July 7, 2014    Clinical Article

15 Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs - a systematic review and network meta-analysis Full Text Health and Quality of Life Outcomes , July 22, 2014    Free full text    Evidence Based Medicine    Review Article

16 Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: A systematic review and meta-analysis Seminars in Arthritis and Rheumatism, June 27, 2014    Evidence Based Medicine    Review Article

17 Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study Rheumatology, February 11, 2014    Clinical Article

18 Joint damage progression in patients with rheumatoid arthritis in clinical remission. do biologics perform better than synthetic antirheumatic drugs? The Journal of Rheumatology, July 22, 2014    Clinical Article

19 Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: A non-inferiority randomised controlled trial Annals of Rheumatic Diseases, July 16, 2014    Clinical Article

20 Relation of temperature and humidity to the risk of recurrent gout attacks American Journal of Epidemiology, July 11, 2014    Clinical Article

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close